Table 1 Clinicopathological features of HGSOC tissues with regard to the relative expression of Fn14
Patients’ characteristics | Total | Fn14 IHC (n) | P | |
|---|---|---|---|---|
n | low expression | high expression | ||
71 | (n = 48, 67.6%) | (n = 23, 43.3%) | ||
Age(y) | ||||
  ≤ 50 | 19 | 10 (52.6%) | 9 (47.4%) | 0.152 |
 >50 | 52 | 38 (73.1%) | 14 (26.9%) | |
FIGO stage | ||||
 I-II | 8 | 1 (12.5%) | 7 (87.5%) | 0.001 |
 III-IV | 63 | 47 (74.6%) | 16 (25.4%) | |
Ascites | ||||
 positive | 58 | 41 (70.7%) | 17 (29.3%) | 0.327 |
 negative | 13 | 7 (53.8%) | 6 (46.2%) | |
Residual lesions | ||||
 <2 cm | 62 | 42 (67.7%) | 20 (32.3%) | > 0.999 |
  ≥ 2 cm | 9 | 6 (66.7%) | 3 (33.3%) | |